Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.
SRAs

Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.

SRAs

-

-

Develop more effective ways to prioritize PADO products within current legal frameworks

-

GAP-f members developing proposals to communicate to FDA and EMA

-

-

-

-

-

Sub-Actions & Milestones

Updates

Notes

Responsible